These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17154713)

  • 1. Thrombogenicity of the Hemobahn/Viabahn in the SFA.
    Bray PJ; Bray AE
    J Endovasc Ther; 2006 Dec; 13(6):783-4. PubMed ID: 17154713
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provisionial SFA stenting.
    Bates MC
    Catheter Cardiovasc Interv; 2007 May; 69(6):890-3. PubMed ID: 17191215
    [No Abstract]   [Full Text] [Related]  

  • 4. Regarding: Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
    Teebken OE; Bauermeister G; Pichlmaier AM
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):118. PubMed ID: 18440251
    [No Abstract]   [Full Text] [Related]  

  • 5. Stents (grafting) should be the primary treatment for symptomatic superficial femoral artery disease.
    Ansel GM
    Catheter Cardiovasc Interv; 2007 May; 69(6):886-9. PubMed ID: 17427903
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience.
    Fischer M; Schwabe C; Schulte KL
    J Endovasc Ther; 2006 Jun; 13(3):281-90. PubMed ID: 16784314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited commentary.
    Rasmussen TE
    J Vasc Surg; 2009 Sep; 50(3):548. PubMed ID: 19700092
    [No Abstract]   [Full Text] [Related]  

  • 8. Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.
    Hillegass WB
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1096. PubMed ID: 19953522
    [No Abstract]   [Full Text] [Related]  

  • 9. Regarding "Stent grafts vs femoropopliteal bypass".
    Takagi H; Tanabashi T; Kawai N; Umemoto T
    J Vasc Surg; 2007 Aug; 46(2):399. PubMed ID: 17664120
    [No Abstract]   [Full Text] [Related]  

  • 10. The double-barrel stent-graft catastrophe.
    Abadal JM; de la Quintana M; Vazquez E; Alvarez MJ; Araujo M; Galvez E; Ramirez B; Lago I
    J Vasc Interv Radiol; 2015 Jul; 26(7):1007-8. PubMed ID: 26095269
    [No Abstract]   [Full Text] [Related]  

  • 11. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
    Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
    J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular stent graft repair of iatrogenic popliteal artery injuries--a report of 2 cases.
    Kovacs F; Pollock JG; DeNunzio M
    Vasc Endovascular Surg; 2012 Apr; 46(3):269-72. PubMed ID: 22504510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
    Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ
    J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the Viabahn Padova sutureless technique for challenging anastomosis between a prosthetic graft and a circumferentially calcified target artery.
    Piazza M; Bonvini S; Ferretto L; Menegolo M; Frigatti P; Ricotta JJ; Grego F
    J Endovasc Ther; 2012 Jun; 19(3):457-60. PubMed ID: 22788901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication.
    Schneider PA
    J Vasc Surg; 2017 Sep; 66(3):916-923. PubMed ID: 28842077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde stent-graft angioplasty of superficial femoral artery occlusion in a claudicant.
    Lesperance RN; Singh NN; Curry TK; Andersen CA
    Vasc Endovascular Surg; 2009; 43(1):83-6. PubMed ID: 18829584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of total endoluminal superficial femoral artery bypass.
    Gable D
    J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease.
    Golchehr B; Lensvelt MM; Fritschy WM; Holewijn S; van Walraven LA; van Oostayen JA; Zeebregts CJ; Reijnen MM
    J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery].
    Fischer M; Langhoff R; Schulte KL
    Zentralbl Chir; 2003 Sep; 128(9):740-5. PubMed ID: 14533042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
    Kedora J; Hohmann S; Garrett W; Munschaur C; Theune B; Gable D
    J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.